{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:52:58Z","timestamp":1793494378065,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11102-021-01202-y","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T19:04:21Z","timestamp":1642878261000},"page":"52-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Opioids and pituitary function: expert opinion"],"prefix":"10.1007","volume":"25","author":[{"given":"M\u00f4nica R.","family":"Gadelha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-0643","authenticated-orcid":false,"given":"Niki","family":"Karavitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Fudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Bettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-8476","authenticated-orcid":false,"given":"Hershel","family":"Raff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Ben-Shlomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,23]]},"reference":[{"issue":"2","key":"1202_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.janh.2017.02.001","volume":"3","author":"K Brook","year":"2017","unstructured":"Brook K, Bennett J, Desai SP (2017) The chemical history of morphine: an 8000-year journey, from resin to de-novo synthesis. J Anesth Hist 3(2):50\u201355. https:\/\/doi.org\/10.1016\/j.janh.2017.02.001","journal-title":"J Anesth Hist"},{"key":"1202_CR2","volume-title":"Opioid addiction","author":"M Azadfard","year":"2021","unstructured":"Azadfard M, Huecker MR, Leaming JM (2021) Opioid addiction. StatPearls, Treasure Island"},{"key":"1202_CR3","volume-title":"Opioid toxicity","author":"RC Oelhaf","year":"2021","unstructured":"Oelhaf RC, Del Pozo E, Azadfard M (2021) Opioid toxicity. StatPearls, Treasure Island"},{"key":"1202_CR4","volume-title":"Opioid antagonists","author":"J Theriot","year":"2021","unstructured":"Theriot J, Sabir S, Azadfard M (2021) Opioid antagonists. StatPearls, Treasure Island"},{"issue":"12","key":"1202_CR5","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1185\/03007995.2014.952717","volume":"30","author":"RB Raffa","year":"2014","unstructured":"Raffa RB (2014) On subclasses of opioid analgesics. Curr Med Res Opin 30(12):2579\u20132584. https:\/\/doi.org\/10.1185\/03007995.2014.952717","journal-title":"Curr Med Res Opin"},{"key":"1202_CR6","volume-title":"Opioid","author":"N Grewal","year":"2021","unstructured":"Grewal N, Huecker MR (2021) Opioid. StatPearls, Treasure Island"},{"issue":"15","key":"1202_CR7","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R (2016) CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA 315(15):1624\u20131645. https:\/\/doi.org\/10.1001\/jama.2016.1464","journal-title":"JAMA"},{"key":"1202_CR8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz022","author":"F de Vries","year":"2020","unstructured":"de Vries F, Bruin M, Lobatto DJ, Dekkers OM, Schoones JW, van Furth WR, Pereira AM, Karavitaki N, Biermasz NR, Zamanipoor Najafabadi AH (2020) Opioids and their endocrine effects: a systematic review and meta-analysis. J Clin Endocrinol Metab 105(3):1020\u20139. https:\/\/doi.org\/10.1210\/clinem\/dgz022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1202_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL (2021) Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep 70(6):202\u2013207. https:\/\/doi.org\/10.15585\/mmwr.mm7006a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"1202_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/SPC.0000000000000495","volume":"14","author":"C Stein","year":"2020","unstructured":"Stein C (2020) Opioid analgesia: recent developments. Curr Opin Support Palliat Care 14(2):112\u2013117. https:\/\/doi.org\/10.1097\/SPC.0000000000000495","journal-title":"Curr Opin Support Palliat Care"},{"issue":"6","key":"1202_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/AJP.0000000000000708","volume":"35","author":"S Eisdorfer","year":"2019","unstructured":"Eisdorfer S, Galinkin J (2019) Opioid use disorder in children and adolescents: risk factors, detection, and treatment. Clin J Pain 35(6):521\u2013524. https:\/\/doi.org\/10.1097\/AJP.0000000000000708","journal-title":"Clin J Pain"},{"key":"1202_CR12","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00259.2021","author":"JT Bateman","year":"2021","unstructured":"Bateman JT, Levitt ES (2021) Evaluation of G protein bias and beta-arrestin 2 signaling in opioid-induced respiratory depression. Am J Physiol Cell Physiol. https:\/\/doi.org\/10.1152\/ajpcell.00259.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"1202_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15580","author":"JT Bateman","year":"2021","unstructured":"Bateman JT, Saunders SE, Levitt ES (2021) Understanding and countering opioid-induced respiratory depression. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.15580","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1202_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2213-8587(19)30254-2","volume":"8","author":"A Fountas","year":"2020","unstructured":"Fountas A, Van Uum S, Karavitaki N (2020) Opioid-induced endocrinopathies. Lancet Diabetes Endocrinol 8(1):68\u201380. https:\/\/doi.org\/10.1016\/S2213-8587(19)30254-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1202_CR15","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4158\/EP-2019-0177","volume":"25","author":"ZI Saeed","year":"2019","unstructured":"Saeed ZI, Bancos I, Donegan D (2019) Current knowledge and practices of heath care professionals on opioid-induced adrenal insufficiency. Endocr Pract 25(10):1012\u20131021. https:\/\/doi.org\/10.4158\/EP-2019-0177","journal-title":"Endocr Pract"},{"issue":"3 Suppl","key":"1202_CR16","doi-asserted-by":"publisher","first-page":"ES93","DOI":"10.36076\/ppj.2012\/15\/ES93","volume":"15","author":"HS Smith","year":"2012","unstructured":"Smith HS (2012) Opioids and neuropathic pain. Pain Physician 15(3 Suppl):ES93\u2013ES110","journal-title":"Pain Physician"},{"issue":"5","key":"1202_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5055\/jom.2011.0080","volume":"7","author":"HS Smith","year":"2011","unstructured":"Smith HS, Meek PD (2011) Pain responsiveness to opioids: central versus peripheral neuropathic pain. J Opioid Manag 7(5):391\u2013400. https:\/\/doi.org\/10.5055\/jom.2011.0080","journal-title":"J Opioid Manag"},{"key":"1202_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aab4068","author":"I Masuho","year":"2015","unstructured":"Masuho I, Ostrovskaya O, Kramer GM, Jones CD, Xie K, Martemyanov KA (2015) Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors. Sci Signal 8(405):ra123. https:\/\/doi.org\/10.1126\/scisignal.aab4068","journal-title":"Sci Signal"},{"issue":"6","key":"1202_CR19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR (2011) Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115(6):1363\u20131381. https:\/\/doi.org\/10.1097\/ALN.0b013e318238bba6","journal-title":"Anesthesiology"},{"issue":"4","key":"1202_CR20","doi-asserted-by":"publisher","first-page":"E343","DOI":"10.36076\/ppj.2011\/14\/E343","volume":"14","author":"R Vallejo","year":"2011","unstructured":"Vallejo R, Barkin RL, Wang VC (2011) Pharmacology of opioids in the treatment of chronic pain syndromes. Pain Physician 14(4):E343-360","journal-title":"Pain Physician"},{"key":"1202_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","volume":"73","author":"M Waldhoer","year":"2004","unstructured":"Waldhoer M, Bartlett SE, Whistler JL (2004) Opioid receptors. Annu Rev Biochem 73:953\u2013990. https:\/\/doi.org\/10.1146\/annurev.biochem.73.011303.073940","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"1202_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/ALN.0000000000002184","volume":"128","author":"A Dahan","year":"2018","unstructured":"Dahan A, van der Schrier R, Smith T, Aarts L, van Velzen M, Niesters M (2018) Averting opioid-induced respiratory depression without affecting analgesia. Anesthesiology 128(5):1027\u20131037. https:\/\/doi.org\/10.1097\/ALN.0000000000002184","journal-title":"Anesthesiology"},{"issue":"5","key":"1202_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1021\/jm00299a003","volume":"13","author":"E Kutter","year":"1970","unstructured":"Kutter E (1970) Structure-activity correlations of morphine-like analgetics based on efficiencies following intravenous and intraventricular application. J Med Chem 13(5):801\u2013805. https:\/\/doi.org\/10.1021\/jm00299a003","journal-title":"J Med Chem"},{"issue":"7","key":"1202_CR24","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/open.201900115","volume":"8","author":"K Mazak","year":"2019","unstructured":"Mazak K, Noszal B, Hosztafi S (2019) Advances in the physicochemical profiling of opioid compounds of therapeutic interest. ChemistryOpen 8(7):879\u2013887. https:\/\/doi.org\/10.1002\/open.201900115","journal-title":"ChemistryOpen"},{"issue":"3","key":"1202_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3181\/00379727-147-38444","volume":"147","author":"WH Oldendorf","year":"1974","unstructured":"Oldendorf WH (1974) Lipid solubility and drug penetration of the blood brain barrier. Proc Soc Exp Biol Med 147(3):813\u2013815. https:\/\/doi.org\/10.3181\/00379727-147-38444","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"1202_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12987-017-0080-3","volume":"14","author":"CP Schaefer","year":"2017","unstructured":"Schaefer CP, Tome ME, Davis TP (2017) The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse. Fluids Barriers CNS 14(1):32. https:\/\/doi.org\/10.1186\/s12987-017-0080-3","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"1202_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jcpt.12196","volume":"39","author":"RB Raffa","year":"2014","unstructured":"Raffa RB, Haidery M, Huang HM, Kalladeen K, Lockstein DE, Ono H, Shope MJ, Sowunmi OA, Tran JK, Pergolizzi JV Jr (2014) The clinical analgesic efficacy of buprenorphine. J Clin Pharm Ther 39(6):577\u2013583. https:\/\/doi.org\/10.1111\/jcpt.12196","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"1202_CR28","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/pm\/pnz356","volume":"21","author":"L Webster","year":"2020","unstructured":"Webster L, Gudin J, Raffa RB, Kuchera J, Rauck R, Fudin J, Adler J, Mallick-Searle T (2020) Understanding buprenorphine for use in chronic pain: expert opinion. Pain Med 21(4):714\u2013723. https:\/\/doi.org\/10.1093\/pm\/pnz356","journal-title":"Pain Med"},{"issue":"3","key":"1202_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","volume":"59","author":"DA Volpe","year":"2011","unstructured":"Volpe DA, McMahon Tobin GA, Mellon RD, Katki AG, Parker RJ, Colatsky T, Kropp TJ, Verbois SL (2011) Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol 59(3):385\u2013390. https:\/\/doi.org\/10.1016\/j.yrtph.2010.12.007","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"1202_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0304-3959(89)90118-8","volume":"36","author":"HJ McQuay","year":"1989","unstructured":"McQuay HJ, Sullivan AF, Smallman K, Dickenson AH (1989) Intrathecal opioids, potency and lipophilicity. Pain 36(1):111\u2013115. https:\/\/doi.org\/10.1016\/0304-3959(89)90118-8","journal-title":"Pain"},{"issue":"1","key":"1202_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12916-020-01528-7","volume":"18","author":"GC Richards","year":"2020","unstructured":"Richards GC, Mahtani KR, Muthee TB, DeVito NJ, Koshiaris C, Aronson JK, Goldacre B, Heneghan CJ (2020) Factors associated with the prescribing of high-dose opioids in primary care: a systematic review and meta-analysis. BMC Med 18(1):68. https:\/\/doi.org\/10.1186\/s12916-020-01528-7","journal-title":"BMC Med"},{"issue":"4","key":"1202_CR32","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/EJE-18-0270","volume":"179","author":"A Fountas","year":"2018","unstructured":"Fountas A, Chai ST, Kourkouti C, Karavitaki N (2018) Mechanisms of endocrinology: endocrinology of opioids. Eur J Endocrinol 179(4):R183\u2013R196. https:\/\/doi.org\/10.1530\/EJE-18-0270","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1202_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1210\/er.2009-0009","volume":"31","author":"C Vuong","year":"2010","unstructured":"Vuong C, Van Uum SH, O\u2019Dell LE, Lutfy K, Friedman TC (2010) The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 31(1):98\u2013132. https:\/\/doi.org\/10.1210\/er.2009-0009","journal-title":"Endocr Rev"},{"issue":"2","key":"1202_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1677\/joe.0.0780299","volume":"78","author":"V Purohit","year":"1978","unstructured":"Purohit V, Singh HH, Ahluwalia BS (1978) Failure of methadone-treated human testes to respond to the stimulatory effect of human chorionic gonadotrophin on testosterone biosynthesis in vitro. J Endocrinol 78(2):299\u2013300. https:\/\/doi.org\/10.1677\/joe.0.0780299","journal-title":"J Endocrinol"},{"issue":"2","key":"1202_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2605.1988.tb00984.x","volume":"11","author":"G Ragni","year":"1988","unstructured":"Ragni G, De Lauretis L, Bestetti O, Sghedoni D, Gambaro V (1988) Gonadal function in male heroin and methadone addicts. Int J Androl 11(2):93\u2013100. https:\/\/doi.org\/10.1111\/j.1365-2605.1988.tb00984.x","journal-title":"Int J Androl"},{"key":"1202_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reprotox.2012.11.010","volume":"36","author":"MR Safarinejad","year":"2013","unstructured":"Safarinejad MR, Asgari SA, Farshi A, Ghaedi G, Kolahi AA, Iravani S, Khoshdel AR (2013) The effects of opiate consumption on serum reproductive hormone levels, sperm parameters, seminal plasma antioxidant capacity and sperm DNA integrity. Reprod Toxicol 36:18\u201323. https:\/\/doi.org\/10.1016\/j.reprotox.2012.11.010","journal-title":"Reprod Toxicol"},{"issue":"12","key":"1202_CR37","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s40618-018-0964-3","volume":"41","author":"F Coluzzi","year":"2018","unstructured":"Coluzzi F, Billeci D, Maggi M, Corona G (2018) Testosterone deficiency in non-cancer opioid-treated patients. J Endocrinol Invest 41(12):1377\u20131388. https:\/\/doi.org\/10.1007\/s40618-018-0964-3","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"1202_CR38","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/0002-9378(74)90667-x","volume":"118","author":"MA Pelosi","year":"1974","unstructured":"Pelosi MA, Sama JC, Caterini H, Kaminetzky HA (1974) Galactorrhea-amenorrhea syndrome associated with heroin addiction. Am J Obstet Gynecol 118(7):966\u2013970. https:\/\/doi.org\/10.1016\/0002-9378(74)90667-x","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1202_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/j.pain.0000000000000691","volume":"158","author":"E Wersocki","year":"2017","unstructured":"Wersocki E, Bedson J, Chen Y, LeResche L, Dunn KM (2017) Comprehensive systematic review of long-term opioids in women with chronic noncancer pain and associated reproductive dysfunction (hypothalamic\u2013pituitary\u2013gonadal axis disruption). Pain 158(1):8\u201316. https:\/\/doi.org\/10.1097\/j.pain.0000000000000691","journal-title":"Pain"},{"issue":"Suppl 1","key":"1202_CR40","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/j.psyneuen.2009.05.013","volume":"34","author":"AM Aloisi","year":"2009","unstructured":"Aloisi AM, Aurilio C, Bachiocco V, Biasi G, Fiorenzani P, Pace MC, Paci V, Pari G, Passavanti G, Ravaioli L, Sindaco G, Vellucci R, Ceccarelli I (2009) Endocrine consequences of opioid therapy. Psychoneuroendocrinology 34(Suppl 1):S162-168. https:\/\/doi.org\/10.1016\/j.psyneuen.2009.05.013","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"1202_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1054\/jpai.2002.126790","volume":"3","author":"HW Daniell","year":"2002","unstructured":"Daniell HW (2002) Hypogonadism in men consuming sustained-action oral opioids. J Pain 3(5):377\u2013384. https:\/\/doi.org\/10.1054\/jpai.2002.126790","journal-title":"J Pain"},{"issue":"12","key":"1202_CR42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.amjmed.2014.07.015","volume":"127","author":"A Rubinstein","year":"2014","unstructured":"Rubinstein A, Carpenter DM (2014) Elucidating risk factors for androgen deficiency associated with daily opioid use. Am J Med 127(12):1195\u20131201. https:\/\/doi.org\/10.1016\/j.amjmed.2014.07.015","journal-title":"Am J Med"},{"issue":"10","key":"1202_CR43","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/AJP.0b013e31827c7b5d","volume":"29","author":"AL Rubinstein","year":"2013","unstructured":"Rubinstein AL, Carpenter DM, Minkoff JR (2013) Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids. Clin J Pain 29(10):840\u2013845. https:\/\/doi.org\/10.1097\/AJP.0b013e31827c7b5d","journal-title":"Clin J Pain"},{"issue":"4","key":"1202_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/pm\/pnw182","volume":"18","author":"AL Rubinstein","year":"2017","unstructured":"Rubinstein AL, Carpenter DM (2017) Association between commonly prescribed opioids and androgen deficiency in men: a retrospective cohort analysis. Pain Med 18(4):637\u2013644. https:\/\/doi.org\/10.1093\/pm\/pnw182","journal-title":"Pain Med"},{"issue":"1","key":"1202_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1210\/jc.2004-0929","volume":"90","author":"N Bliesener","year":"2005","unstructured":"Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D (2005) Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 90(1):203\u2013206. https:\/\/doi.org\/10.1210\/jc.2004-0929","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1202_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jsxm.2017.12.004","volume":"15","author":"A Yee","year":"2018","unstructured":"Yee A, Loh HS, Danaee M, Riahi S, Ng CG, Sulaiman AH (2018) Plasma testosterone and sexual function in Southeast Asian men receiving methadone and buprenorphine maintenance treatment. J Sex Med 15(2):159\u2013166. https:\/\/doi.org\/10.1016\/j.jsxm.2017.12.004","journal-title":"J Sex Med"},{"issue":"1","key":"1202_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","volume":"9","author":"J Gudin","year":"2020","unstructured":"Gudin J, Fudin J (2020) A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain. Pain Ther 9(1):41\u201354. https:\/\/doi.org\/10.1007\/s40122-019-00143-6","journal-title":"Pain Ther"},{"issue":"4","key":"1202_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/2049463716657363","volume":"10","author":"RM Langford","year":"2016","unstructured":"Langford RM, Knaggs R, Farquhar-Smith P, Dickenson AH (2016) Is tapentadol different from classical opioids? A review of the evidence. Br J Pain 10(4):217\u2013221. https:\/\/doi.org\/10.1177\/2049463716657363","journal-title":"Br J Pain"},{"key":"1202_CR49","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-13-0071","volume":"2014","author":"C Policola","year":"2014","unstructured":"Policola C, Stokes V, Karavitaki N, Grossman A (2014) Adrenal insufficiency in acute oral opiate therapy. Endocrinol Diabetes Metab Case Rep 2014:130071. https:\/\/doi.org\/10.1530\/EDM-13-0071","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"1202_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/bcpt.13577","volume":"128","author":"DJ Corsi","year":"2021","unstructured":"Corsi DJ, Murphy MSQ (2021) The effects of opioids on female fertility, pregnancy and the breastfeeding mother\u2013infant dyad: a review. Basic Clin Pharmacol Toxicol 128(5):635\u2013641. https:\/\/doi.org\/10.1111\/bcpt.13577","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"1202_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jpain.2005.10.009","volume":"7","author":"HW Daniell","year":"2006","unstructured":"Daniell HW, Lentz R, Mazer NA (2006) Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 7(3):200\u2013210. https:\/\/doi.org\/10.1016\/j.jpain.2005.10.009","journal-title":"J Pain"},{"key":"1202_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1477-7827-9-26","volume":"9","author":"AM Aloisi","year":"2011","unstructured":"Aloisi AM, Ceccarelli I, Carlucci M, Suman A, Sindaco G, Mameli S, Paci V, Ravaioli L, Passavanti G, Bachiocco V, Pari G (2011) Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients. Reprod Biol Endocrinol 9:26. https:\/\/doi.org\/10.1186\/1477-7827-9-26","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"1202_CR53","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.j.pain.0000460308.86819.aa","volume":"156","author":"S Basaria","year":"2015","unstructured":"Basaria S, Travison TG, Alford D, Knapp PE, Teeter K, Cahalan C, Eder R, Lakshman K, Bachman E, Mensing G, Martel MO, Le D, Stroh H, Bhasin S, Wasan AD, Edwards RR (2015) Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain 156(2):280\u2013288. https:\/\/doi.org\/10.1097\/01.j.pain.0000460308.86819.aa","journal-title":"Pain"},{"issue":"6","key":"1202_CR54","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/EJE-19-0979","volume":"182","author":"D Glintborg","year":"2020","unstructured":"Glintborg D, Vaegter HB, Christensen LL, Bendix E, Graven-Nielsen T, Andersen PG, Andersen M (2020) Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial. Eur J Endocrinol 182(6):539\u2013548. https:\/\/doi.org\/10.1530\/EJE-19-0979","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1202_CR55","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.17141","volume":"2","author":"GK Jasuja","year":"2019","unstructured":"Jasuja GK, Ameli O, Reisman JI, Rose AJ, Miller DR, Berlowitz DR, Bhasin S (2019) Health outcomes among long-term opioid users with testosterone prescription in the veterans health administration. JAMA Netw Open 2(12):e1917141. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.17141","journal-title":"JAMA Netw Open"},{"key":"1202_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/978-3-642-69928-3_83","volume":"8","author":"S Lafisca","year":"1985","unstructured":"Lafisca S, Bolelli G, Franceschetti F, Danieli A, Tagliaro F, Marigo M, Flamigni C (1985) Free and bound testosterone in male heroin addicts. Arch Toxicol Suppl 8:394\u2013397. https:\/\/doi.org\/10.1007\/978-3-642-69928-3_83","journal-title":"Arch Toxicol Suppl"},{"issue":"1","key":"1202_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1055\/s-2008-1076715","volume":"117","author":"LA Fraser","year":"2009","unstructured":"Fraser LA, Morrison D, Morley-Forster P, Paul TL, Tokmakejian S, Larry Nicholson R, Bureau Y, Friedman TC, Van Uum SH (2009) Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 117(1):38\u201343. https:\/\/doi.org\/10.1055\/s-2008-1076715","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"1202_CR58","doi-asserted-by":"publisher","first-page":"312","DOI":"10.18502\/ijps.v16i3.6257","volume":"16","author":"SS Moeeni","year":"2021","unstructured":"Moeeni SS, Rastgoo Sisakht R, Vousooghi N, Kamali K, Raisi F, Mokri A (2021) Comparing sexual function between opioid dependents consuming methadone or opium tincture. Iran J Psychiatry 16(3):312\u2013319. https:\/\/doi.org\/10.18502\/ijps.v16i3.6257","journal-title":"Iran J Psychiatry"},{"issue":"6","key":"1202_CR59","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","volume":"85","author":"R Abs","year":"2000","unstructured":"Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K (2000) Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 85(6):2215\u20132222. https:\/\/doi.org\/10.1210\/jcem.85.6.6615","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1202_CR60","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888\u20133921. https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"key":"1202_CR61","volume-title":"Chronic pain","author":"AM Dydyk","year":"2021","unstructured":"Dydyk AM, Yarrarapu SNS, Conermann T (2021) Chronic pain. StatPearls, Treasure Island"},{"issue":"3","key":"1202_CR62","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1530\/EJE-15-1242","volume":"175","author":"S Bensing","year":"2016","unstructured":"Bensing S, Hulting AL, Husebye ES, Kampe O, Lovas K (2016) Management of endocrine disease: epidemiology, quality of life and complications of primary adrenal insufficiency: a review. Eur J Endocrinol 175(3):R107-116. https:\/\/doi.org\/10.1530\/EJE-15-1242","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1202_CR63","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tem.2021.02.004","volume":"32","author":"N Jaschke","year":"2021","unstructured":"Jaschke N, Pahlig S, Pan YX, Hofbauer LC, Gobel A, Rachner TD (2021) From pharmacology to physiology: endocrine functions of mu-opioid receptor networks. Trends Endocrinol Metab 32(5):306\u2013319. https:\/\/doi.org\/10.1016\/j.tem.2021.02.004","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"1202_CR64","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2265.1981.tb00636.x","volume":"14","author":"RC Gaillard","year":"1981","unstructured":"Gaillard RC, Grossman A, Smith R, Rees LH, Besser GM (1981) The effects of a met-enkephalin analogue on ACTH, beta-LPH, beta-endorphin and MET-enkephalin in patients with adrenocortical disease. Clin Endocrinol (Oxf) 14(5):471\u2013478. https:\/\/doi.org\/10.1111\/j.1365-2265.1981.tb00636.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"1202_CR65","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1210\/jc.2004-2554","volume":"90","author":"D Cozzolino","year":"2005","unstructured":"Cozzolino D, Sasso FC, Cataldo D, Gruosso D, Giammarco A, Cavalli A, Di Maggio C, Renzo G, Salvatore T, Giugliano D, Torella R (2005) Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. J Clin Endocrinol Metab 90(9):5167\u20135174. https:\/\/doi.org\/10.1210\/jc.2004-2554","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1202_CR66","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.mayocp.2018.04.010","volume":"93","author":"D Donegan","year":"2018","unstructured":"Donegan D, Bancos I (2018) Opioid-induced adrenal insufficiency. Mayo Clin Proc 93(7):937\u2013944. https:\/\/doi.org\/10.1016\/j.mayocp.2018.04.010","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"1202_CR67","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1210\/jcem-57-3-592","volume":"57","author":"T Taylor","year":"1983","unstructured":"Taylor T, Dluhy RG, Williams GH (1983) Beta-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects. J Clin Endocrinol Metab 57(3):592\u2013596. https:\/\/doi.org\/10.1210\/jcem-57-3-592","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1202_CR68","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1210\/jcem-60-5-891","volume":"60","author":"RS Rittmaster","year":"1985","unstructured":"Rittmaster RS, Cutler GB Jr, Sobel DO, Goldstein DS, Koppelman MC, Loriaux DL, Chrousos GP (1985) Morphine inhibits the pituitary\u2013adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab 60(5):891\u2013895. https:\/\/doi.org\/10.1210\/jcem-60-5-891","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1202_CR69","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/acta.0.1140509","volume":"114","author":"B Allolio","year":"1987","unstructured":"Allolio B, Schulte HM, Deuss U, Kallabis D, Hamel E, Winkelman W (1987) Effect of oral morphine and naloxone on pituitary\u2013adrenal response in man induced by human corticotropin-releasing hormone. Acta Endocrinol (Copenh) 114(4):509\u2013514. https:\/\/doi.org\/10.1530\/acta.0.1140509","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"5","key":"1202_CR70","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1210\/jcem-38-5-736","volume":"38","author":"JM George","year":"1974","unstructured":"George JM, Reier CE, Lanese RR, Rower M (1974) Morphine anesthesia blocks cortisol and growth hormone response to surgical stress in humans. J Clin Endocrinol Metab 38(5):736\u2013741. https:\/\/doi.org\/10.1210\/jcem-38-5-736","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1202_CR71","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/cen.13125","volume":"85","author":"FW Gibb","year":"2016","unstructured":"Gibb FW, Stewart A, Walker BR, Strachan MW (2016) Adrenal insufficiency in patients on long-term opioid analgesia. Clin Endocrinol (Oxf) 85(6):831\u2013835. https:\/\/doi.org\/10.1111\/cen.13125","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1202_CR72","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1365-2265.2007.02779.x","volume":"66","author":"K Mussig","year":"2007","unstructured":"Mussig K, Knaus-Dittmann D, Schmidt H, Morike K, Haring HU (2007) Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment. Clin Endocrinol (Oxf) 66(4):604\u2013605. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02779.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1202_CR73","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1530\/EJE-18-0530","volume":"179","author":"A Lamprecht","year":"2018","unstructured":"Lamprecht A, Sorbello J, Jang C, Torpy DJ, Inder WJ (2018) Secondary adrenal insufficiency and pituitary dysfunction in oral\/transdermal opioid users with non-cancer pain. Eur J Endocrinol 179(6):353\u2013362. https:\/\/doi.org\/10.1530\/EJE-18-0530","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1202_CR74","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.biopsych.2007.05.001","volume":"63","author":"J Kakko","year":"2008","unstructured":"Kakko J, von Wachenfeldt J, Svanborg KD, Lidstrom J, Barr CS, Heilig M (2008) Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence. Biol Psychiatry 63(2):172\u2013177. https:\/\/doi.org\/10.1016\/j.biopsych.2007.05.001","journal-title":"Biol Psychiatry"},{"issue":"4","key":"1202_CR75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/ajad.12187","volume":"24","author":"EA Woodcock","year":"2015","unstructured":"Woodcock EA, Lundahl LH, Burmeister M, Greenwald MK (2015) Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: a pilot study. Am J Addict 24(4):329\u2013335. https:\/\/doi.org\/10.1111\/ajad.12187","journal-title":"Am J Addict"},{"key":"1202_CR76","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab022","author":"BR Javorsky","year":"2021","unstructured":"Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Colon-Franco JM, Findling JW (2021) New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays. J Endocr Soc. 5(4)\u00a0https:\/\/doi.org\/10.1210\/jendso\/bvab022","journal-title":"J Endocr Soc"},{"key":"1202_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14587","author":"C Colling","year":"2021","unstructured":"Colling C, Nachtigall L, Biller BMK, Miller KK (2022) The biochemical diagnosis of adrenal insufficiency with modern cortisol assays: reappraisal in the setting of opioid exposure and hospitalization. Clin Endocrinol (Oxf).\u00a096(1):21-29.\u00a0https:\/\/doi.org\/10.1111\/cen.14587","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1202_CR78","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1365-2796.2005.01483.x","volume":"257","author":"KM Oltmanns","year":"2005","unstructured":"Oltmanns KM, Fehm HL, Peters A (2005) Chronic fentanyl application induces adrenocortical insufficiency. J Intern Med 257(5):478\u2013480","journal-title":"J Intern Med"},{"issue":"8","key":"1202_CR79","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00228-011-0992-9","volume":"67","author":"M Debono","year":"2011","unstructured":"Debono M, Chan S, Rolfe C, Jones TH (2011) Tramadol-induced adrenal insufficiency. Eur J Clin Pharmacol 67(8):865\u2013867. https:\/\/doi.org\/10.1007\/s00228-011-0992-9","journal-title":"Eur J Clin Pharmacol"},{"key":"1202_CR80","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.psyneuen.2015.03.015","volume":"56","author":"MA Nenke","year":"2015","unstructured":"Nenke MA, Haylock CL, Rankin W, Inder WJ, Gagliardi L, Eldridge C, Rolan P, Torpy DJ (2015) Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial. Psychoneuroendocrinology 56:157\u2013167. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.03.015","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"1202_CR81","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP-2020-0297","volume":"26","author":"T Li","year":"2020","unstructured":"Li T, Donegan D, Hooten WM, Bancos I (2020) Clinical presentation and outcomes of opioid-induced adrenal insufficiency. Endocr Pract 26(11):1291\u20131297. https:\/\/doi.org\/10.4158\/EP-2020-0297","journal-title":"Endocr Pract"},{"key":"1202_CR82","doi-asserted-by":"publisher","DOI":"10.1159\/000514216","author":"V Gasco","year":"2021","unstructured":"Gasco V, Bima C, Geranzani A, Giannelli J, Marinelli L, Bona C, Cambria V, Berton AM, Prencipe N, Ghigo E, Maccario M, Grottoli S (2021) Morning serum cortisol level predicts central adrenal insufficiency diagnosed by insulin tolerance test. Neuroendocrinology 111(12):1238-1248. https:\/\/doi.org\/10.1159\/000514216","journal-title":"Neuroendocrinology"},{"key":"1202_CR83","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14388","author":"T Kalaria","year":"2020","unstructured":"Kalaria T, Buch H, Agarwal M, Chaudhari R, Gherman-Ciolac C, Chopra R, Okeke V, Kaur S, Hughes L, Sharrod-Cole H, Ford C, Gama R (2020) Morning serum cortisol is superior to salivary cortisone and cortisol in predicting normal adrenal function in suspected adrenal insufficiency. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.14388","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1202_CR84","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/cen.12039","volume":"78","author":"N El-Farhan","year":"2013","unstructured":"El-Farhan N, Pickett A, Ducroq D, Bailey C, Mitchem K, Morgan N, Armston A, Jones L, Evans C, Rees DA (2013) Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography\u2013mass spectrometry and five automated immunoassays. Clin Endocrinol (Oxf) 78(5):673\u2013680. https:\/\/doi.org\/10.1111\/cen.12039","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1202_CR85","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1210\/jc.2017-02602","volume":"103","author":"GA Ueland","year":"2018","unstructured":"Ueland GA, Methlie P, Oksnes M, Thordarson HB, Sagen J, Kellmann R, Mellgren G, Raeder M, Dahlqvist P, Dahl SR, Thorsby PM, Lovas K, Husebye ES (2018) The short cosyntropin test revisited: new normal reference range using LC\u2013MS\/MS. J Clin Endocrinol Metab 103(4):1696\u20131703. https:\/\/doi.org\/10.1210\/jc.2017-02602","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1202_CR86","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2265.2004.02106.x","volume":"61","author":"PM Mah","year":"2004","unstructured":"Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT, Ross RJ (2004) Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 61(3):367\u2013375","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1202_CR87","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80(4):1523\u20131631. https:\/\/doi.org\/10.1152\/physrev.2000.80.4.1523","journal-title":"Physiol Rev"},{"issue":"3","key":"1202_CR88","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000180040","volume":"21","author":"PP Vescovi","year":"1985","unstructured":"Vescovi PP, Pezzarossa A, Ceresini G, Rastelli G, Valenti G, Gerra G (1985) Effects of dopamine receptor stimulation on opiate-induced modifications of pituitary-gonadal function. Horm Res 21(3):155\u2013159. https:\/\/doi.org\/10.1159\/000180040","journal-title":"Horm Res"},{"issue":"5","key":"1202_CR89","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/AJP.0b013e3181d1059d","volume":"26","author":"A Rhodin","year":"2010","unstructured":"Rhodin A, Stridsberg M, Gordh T (2010) Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain 26(5):374\u2013380. https:\/\/doi.org\/10.1097\/AJP.0b013e3181d1059d","journal-title":"Clin J Pain"},{"issue":"5","key":"1202_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1155\/2011\/807123","volume":"16","author":"D Wong","year":"2011","unstructured":"Wong D, Gray DP, Simmonds M, Rashiq S, Sobolev I, Morrish DW (2011) Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction. Pain Res Manag 16(5):311\u2013316. https:\/\/doi.org\/10.1155\/2011\/807123","journal-title":"Pain Res Manag"},{"issue":"5","key":"1202_CR91","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3892\/etm.2016.3156","volume":"11","author":"A Merdin","year":"2016","unstructured":"Merdin A, Merdin FA, Gunduz S, Bozcuk H, Coskun HS (2016) Opioid endocrinopathy: a clinical problem in patients with cancer pain. Exp Ther Med 11(5):1819\u20131822. https:\/\/doi.org\/10.3892\/etm.2016.3156","journal-title":"Exp Ther Med"},{"issue":"2","key":"1202_CR92","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA, Endocrine S (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1202_CR93","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","volume":"134","author":"S Grassin-Delyle","year":"2012","unstructured":"Grassin-Delyle S, Buenestado A, Naline E, Faisy C, Blouquit-Laye S, Couderc LJ, Le Guen M, Fischler M, Devillier P (2012) Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther 134(3):366\u2013379. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.03.003","journal-title":"Pharmacol Ther"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-021-01202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-021-01202-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-021-01202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T05:50:30Z","timestamp":1644213030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-021-01202-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,23]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1202"],"URL":"https:\/\/doi.org\/10.1007\/s11102-021-01202-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,23]]},"assertion":[{"value":"8 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The interests listed below were not directly related to the work submitted for publication but are provided for completeness. M\u00f4nica R. Gadelha: Speaker for Recordati Rare Diseases, Novartis, Ipsen and Crinetics; Principal Investigator\u2014Clinical trials for Recordati Rare Diseases, Novartis and Crinetics; Scientific advisory board for Novartis, Crinetics, Ipsen and Novo Nordisk. Niki Karavitaki: Speaker for Pfizer, Ipsen, HRA Pharma, Recordati Rare Diseases,\u2014Investigator for Pfizer, Ipsen, Shire\u2014Scientific Advisory Board for Pfizer, Ipsen, Recordati Rare Diseases. Jeffrey Fudin: Lecturer (non-speakers\u2019 bureau) for Abbott Laboratories; Speakers bureau, consulting, advisory boards for AcelRx Pharmaceuticals; Collaborative publications, consulting, advisory boards for BioDelivery Sciences International; Educational studio recording for Collegium Pharmaceutical; Consulting for Firstox Laboratories; Collaborative non-paid poster presentations for GlaxoSmithKline (GSK); Advisory Board for Hisamitsu America; Advisory Board for Hikma Pharmaceuticals; Collaborative non-paid publications for Scilex Pharmaceuticals; Speakers\u2019 bureau, consultant, advisory boards for Salix Pharmaceuticals; Lecture, non-speakers\u2019 bureau for Torrent Pharmaceuticals. Jeffrey Bettinger: National Advisory Board: Hisamitsu America, Inc; Scientific Advisory Board: PainScript. Hershel Raff: Consultant for Corcept Therapeutics; Consultant for Cerium Pharmaceuticals. Anat Ben-Shlomo: Consultant for Recordati Rare Diseases. Principal investigator, Precision Health in the Diagnosis and Treatment of Adrenal Insufficiency, Cedars Sinai Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and\/or animals participants"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}